The U.S. Centers for Disease Control and Prevention’s vaccine advisory committee has decided not to move forward with a proposal that would have halted recommendations for mRNA Covid-19 shots, keeping the guidance in place for now.
The decision comes amid ongoing debate over vaccine safety and effectiveness. Committee members said more data is needed before considering any changes, stressing that current recommendations remain based on evidence showing the vaccines reduce severe illness and hospitalization.
Public reaction has been mixed. Supporters of the vaccines welcomed the move, saying it reinforces trust in scientific review. “It shows the system is working decisions are being made carefully, not politically,” one health advocate noted.
Critics, however, argued that the committee missed an opportunity to reevaluate concerns raised by some groups. “People want transparency and accountability. Delaying the discussion only fuels skepticism,” a parent from Atlanta said.
International observers are watching closely, as U.S. vaccine policy often influences global health strategies. Analysts say the committee’s cautious approach reflects the challenge of balancing public confidence with evolving scientific evidence.
For now, mRNA vaccines remain part of the CDC’s official recommendations, though the debate is far from over. The committee is expected to revisit the issue as new research emerges.
